Diffuse Large B-Cell Lymphoma, Lymphoma Follicular

1 clinical trials · Condition

Record	Firm	Date
A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02596971)	Hoffmann-La Roche	2015-12-22

Every clearance here is in the API, with alerts when new ones post.